The Enterprise Value as of September 2024 (TTM) for LAVA Therapeutics N.V. (LVTX) is 16.19M

According to LAVA Therapeutics N.V.’s latest financial reports and current stock price. The company's current Enterprise Value is 16.19M. This represents a change of 6.14% compared to the average of 15.26M of the last 4 quarters.

LAVA Therapeutics N.V. (LVTX) Historical Enterprise Value (quarterly & annually)

How has LVTX Enterprise Value performed in the past?

The mean historical Enterprise Value of LAVA Therapeutics N.V. over the last ten years is 96.30M. The current 16.19M Enterprise Value has changed 1.58% with respect to the historical average. Over the past ten years (40 quarters), LVTX's Enterprise Value was at its highest in in the December 2020 quarter at 286.88M. The Enterprise Value was at its lowest in in the March 2021 quarter at -132920568.67.

LAVA Therapeutics N.V. (LVTX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of LAVA Therapeutics N.V. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

LAVA Therapeutics N.V. (LVTX) Average Enterprise Value

How has LVTX Enterprise Value performed in the past?

The current Enterprise Value of LAVA Therapeutics N.V. (LVTX) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

LAVA Therapeutics N.V. (LVTX) Enterprise Value vs. Peers

How is LVTX’s Enterprise Value compared to its peers?

LAVA Therapeutics N.V.’s Enterprise Value is less than Anebulo Pharmaceuticals, Inc. (49.05M), less than PMV Pharmaceuticals, Inc. (40.92M), less than Miromatrix Medical Inc. (90.06M), less than ZIVO Bioscience, Inc. (44.34M), greater than Bionomics Limited (-782116.00), less than Edgewise Therapeutics, Inc. (1.54B), less than Ikena Oncology, Inc. (47.83M), less than Design Therapeutics, Inc. (271.25M), greater than Xilio Therapeutics, Inc. (-30542416.00), less than Eliem Therapeutics, Inc. (329.54M), less than Aerovate Therapeutics, Inc. (24.75M), less than Adagene Inc. (46.86M), less than Acrivon Therapeutics, Inc. Common Stock (213.12M), less than Rezolute, Inc. (281.53M), greater than AN2 Therapeutics, Inc. (4.57M), less than Generation Bio Co. (231.64M), greater than Kronos Bio, Inc. (14.32M), less than Erasca, Inc. (677.83M), less than C4 Therapeutics, Inc. (436.29M), greater than Neoleukin Therapeutics, Inc. (-6333315.00), less than Instil Bio, Inc. (497.10M), greater than Achilles Therapeutics plc (-61656377.00), less than NextCure, Inc. (22.52M), less than Assembly Biosciences, Inc. (98.98M),

Build a custom stock screener for LAVA Therapeutics N.V. (LVTX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like LAVA Therapeutics N.V. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

LAVA Therapeutics N.V. (LVTX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like LAVA Therapeutics N.V. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.